EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY-NC-ND 4.0

Triple therapy boosts survival in NSCLC patients with brain metastases: a retrospective cohort study of chemotherapy, ICIs, and antiangiogenic agents

Dingyi Yang, Erha Munai, Siwei Zeng, Dan Tao, Ze Yuan, Liang Du, Wei Zhou, Yongzhong Wu, Xiao-Dong Zhu

Cancer Immunology, Immunotherapy · 2024

DOI: 10.1007/s00262-024-03797-0 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Cancer Immunology, Immunotherapy, 2024. Verfasst von Dingyi Yang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Guangxi Medical University Cancer Hospital, No. 71, He Di Road, Nanning, 530021, Guangxi, China. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Brain Neoplasms, Lung Neoplasms, Angiogenesis Inhibitors. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation Project, Chongqing Science and Health Joint Medical Research Project, Chongqing Talent Plan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungBrain NeoplasmsLung NeoplasmsAngiogenesis InhibitorsImmune Checkpoint InhibitorsAntineoplastic Combined Chemotherapy ProtocolsHumansRetrospective StudiesMaleFemaleMiddle AgedAgedAdult

Stichwörter der Autor:innen

Brain metastasisImmune-related combination therapyNon-sensitive genetic mutationsNon-small cell lung cancerPeri-brain radiotherapy

Substanzen

Angiogenesis InhibitorsImmune Checkpoint Inhibitors

Autor:innen und Institutionen

  • Department of Radiation Oncology, Guangxi Medical University Cancer Hospital, No. 71, He Di Road, Nanning, 530021, Guangxi, China.
  • Department of Radiation Oncology, Chongqing University Cancer Hospital, Chongqing, China.
  • School of Medicine, Chongqing University, Chongqing, China.
  • Department of Radiation Oncology, Chongqing University Cancer Hospital, Chongqing, China. zhouwei998@cqu.edu.cn.
  • Department of Radiation Oncology, Chongqing University Cancer Hospital, Chongqing, China. cqmdwyz@163.com.
  • Department of Radiation Oncology, Guangxi Medical University Cancer Hospital, No. 71, He Di Road, Nanning, 530021, Guangxi, China. zhuxdonggxmu@126.com.

Förderung

  • National Natural Science Foundation Project
  • Chongqing Science and Health Joint Medical Research Project
  • Chongqing Talent Plan
  • Key Research and Development Program Project of Guangxi Zhuang Autonomous Region
  • Independent Project of Key Laboratory of Early Prevention & Treatment for Regional HighIncidence Tumor

Zitieren

APA

Yang, D., Munai, E., Zeng, S., Tao, D., Yuan, Z., Du, L., Zhou, W., Wu, Y., & Zhu, X. D. (2024). Triple therapy boosts survival in NSCLC patients with brain metastases: a retrospective cohort study of chemotherapy, ICIs, and antiangiogenic agents. Cancer Immunology, Immunotherapy. https://doi.org/10.1007/s00262-024-03797-0

Vancouver

Yang D, Munai E, Zeng S, Tao D, Yuan Z, Du L, et al. Triple therapy boosts survival in NSCLC patients with brain metastases: a retrospective cohort study of chemotherapy, ICIs, and antiangiogenic agents. Cancer Immunology, Immunotherapy. 2024. doi:10.1007/s00262-024-03797-0

BibTeX
@article{Yang2024,
  author = {Yang, Dingyi and Munai, Erha and Zeng, Siwei and Tao, Dan and Yuan, Ze and Du, Liang and Zhou, Wei and Wu, Yongzhong and Zhu, Xiao-Dong},
  title = {Triple therapy boosts survival in NSCLC patients with brain metastases: a retrospective cohort study of chemotherapy, ICIs, and antiangiogenic agents},
  journal = {Cancer Immunology, Immunotherapy},
  year = {2024},
  doi = {10.1007/s00262-024-03797-0}
}
Kostenlos starten →